|
MBNL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.022000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.841200E-01 |
| Normal-vs-Stage2 |
8.344000E-01 |
| Normal-vs-Stage3 |
5.655600E-02 |
| Normal-vs-Stage4 |
5.321800E-03 |
| Stage1-vs-Stage2 |
8.421400E-01 |
| Stage1-vs-Stage3 |
1.738010E-01 |
| Stage1-vs-Stage4 |
1.820100E-02 |
| Stage2-vs-Stage3 |
3.975600E-01 |
| Stage2-vs-Stage4 |
1.922200E-01 |
| Stage3-vs-Stage4 |
4.245400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.396370E-01 |
| Normal-vs-AfricanAmerican |
5.679900E-03 |
| Normal-vs-Asian |
5.343400E-01 |
| Caucasian-vs-AfricanAmerican |
9.143600E-02 |
| Caucasian-vs-Asian |
2.683000E-01 |
| AfricanAmerican-vs-Asian |
5.783700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.344000E-01 |
| Normal-vs-Female |
1.029840E-01 |
| Male-vs-Female |
8.128600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.115200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.449200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.212100E-02 |
| Normal-vs-Age(81-100Yrs) |
2.836400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.035800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.596000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.534400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.863400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.264400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.643200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.376000E-01 |
| Normal-vs-Grade 2 |
8.130600E-01 |
| Normal-vs-Grade 3 |
1.576220E-02 |
| Normal-vs-Grade 4 |
6.20989999999821E-05 |
| Grade 1-vs-Grade 2 |
6.872400E-01 |
| Grade 1-vs-Grade 3 |
5.431900E-02 |
| Grade 1-vs-Grade 4 |
4.756100E-03 |
| Grade 2-vs-Grade 3 |
5.282900E-03 |
| Grade 2-vs-Grade 4 |
2.21799999999828E-05 |
| Grade 3-vs-Grade 4 |
2.046300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.369800E-01 |
| Normal-vs-ccB subtype |
2.966000E-02 |
| ccA subtype-vs-ccB subtype |
1.244990E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.912190E-01 |
| Normal-vs-N1 |
2.317200E-01 |
| N0-vs-N1 |
5.442000E-01 |
|
|
